Clinical trials are essential for evaluating potential new treatments, advancing the standard of care, and improving patient outcomes, yet only about five percent of Americans participate in ...

People often reject trial participation because they ... more about them and if they are a good fit. Other barriers for people considering a clinical trial include eligibility and costs.

In this video interview, Michel van Harten, MD, CEO, myTomorrows, discusses how patient education and remote monitoring can ...

If the future of oncology research is to be inclusive, efficient, and representative, community-based clinical trials must be ...

Removing barriers to clinical trial participation for underserved groups is an essential part of addressing health inequalities. Getting there, however, is easier said than done. The Food and Drug ...

Understanding why people join clinical trials is essential to improving recruitment and designing better research. Explores ...

Oncology researchers at Atrium Health Levine Cancer share what they want everyone to know about the power of clinical trials ...

In recognition of Clinical Trials Day, the Coalition to Transform Clinical Trial Engagement (CTCTE) proudly announces the launch of the Champions for Change ...

Clinical trials are essential for evaluating potential new treatments, advancing the standard of care, and improving patient outcomes, yet only about five percent of Americans participate in them.